Natalie Calcatera
Papers
1
Total Citations
35
H-Index
1
About
Dr. Natalie Calcatera is a surgical oncologist whose research centers on the surgical management of rare and aggressive endocrine tumors, particularly adrenocortical carcinoma (ACC). Her landmark study, "Minimally Invasive Adrenalectomy for Adrenocortical Carcinoma: Five‐Year Trends and Predictors of Conversion" (2017, 35 citations), critically examined the evolving role of minimally invasive (MI) approaches for ACC—a disease where complete surgical resection offers the only chance of cure. By analyzing national trends and identifying risk factors for conversion from MI to open surgery, Calcatera provided essential guidance for surgeons navigating the delicate balance between oncologic rigor and minimally invasive benefits. Her work has been instrumental in shaping clinical decision-making for this rare but deadly malignancy, highlighting the importance of patient selection and surgical expertise. With over 35 citations, this study remains a foundational reference for surgeons and researchers debating the safety and efficacy of MI adrenalectomy for ACC. Dr. Calcatera’s contributions continue to influence best practices in endocrine surgery and improve outcomes for patients facing this challenging diagnosis.
Research Focus
Key Achievements
Top Papers
- 1